GE HealthCare has unveiled a new set of upgrades for interventional imaging systems: the Allia upgrade pathways, which bring latest-generation image-guided capabilities to already-installed Innova and Discovery units without requiring a full room replacement. In practice, hospitals and clinics can modernize their angiography and cath labs with artificial intelligence and dose-reduction tools while preserving existing infrastructure.
What GE HealthCare announced
Released in late June 2026, the program builds technological bridges between equipment generations. Image-guided systems (IGS) from the Innova and Discovery lines, many of them more than a decade old, gain access to features previously exclusive to the newer Allia IGS and Allia IGS Pulse platforms. According to Jyoti Gera, who leads cardiovascular and interventional solutions at the company, the goal is to “help customers modernize on their own terms by extending the capabilities of existing systems while providing access to the latest Allia innovations.”
The context explains the strategy: roughly one third of interventional X-ray systems in Europe are estimated to be more than ten years old. Rather than retiring that installed base, the manufacturer is betting on modular upgrades that avoid civil construction and reduce room downtime, a critical factor for high-volume services. Availability spans the United States and other markets where Allia IGS and Allia IGS Pulse are cleared for sale, with the specific menu of features gated by each region’s regulatory status.
Technologies coming to the installed base
Upgrade packages vary with each system’s configuration and country-level regulatory clearances, but the announced portfolio is broad. Highlights include CleaRecon DL, a deep-learning reconstruction that improves cone-beam CT (CBCT) image quality by reducing artifacts. There is also 3DStent for three-dimensional coronary stent visualization and the OmnifyXR suite, which uses augmented reality to guide procedures.
The list also includes Embo ASSIST, an AI tool supporting embolization strategies, Medis quantitative flow ratio (QFR) software for coronary physiology assessment, and the AVVIGO+ intravascular imaging platform. For services that rely on validated vendors, it is worth tracking how these features stack up against the top AI vendors by FDA approvals, since interoperability and regulatory track record weigh heavily on purchasing decisions.
Dose reduction and image quality
The core of the value proposition is the intelligent image chain. AutoRight, described by GE HealthCare as the industry’s first AI-based interventional image chain, automatically adjusts up to seven parameters in real time to balance image quality and radiation dose. The AutoRight PLUS version on Allia IGS Pulse optimizes those parameters, including focal spot shape.
The gains are substantial: myIQ technology can reduce noise by up to 53% or boost contrast by up to 29% in dynamic acquisitions, and reaches up to 77% noise reduction or 70% contrast increase in fluoroscopy without raising dose. For patients undergoing long procedures and for teams working beside the radiation source, managing dose is both a safety issue and a matter of service sustainability. The theme aligns with the broader evolution of X-ray equipment reaching new care settings.
Upgrade versus replace: cath and angio lab economics
Replacing a fixed angiography system is an expensive, drawn-out capital project, usually involving room refurbishment, shielding, flooring work, and weeks of downtime. By enabling software and component upgrades on existing equipment, GE HealthCare shifts part of that investment away from heavy capex toward incremental updates. This preserves infrastructure, minimizes clinical disruption, and extends the lifespan of the interventional room.
There is a sustainability argument too: extending the life of the installed base reduces the disposal of still-functional equipment and the resource use tied to manufacturing entirely new systems. The company itself runs refurbishment programs — 100% of Allia IGS 5 systems fitted with a 31 cm detector are eligible for refurbishment under its Silver Preferred program, reinforcing a circular-economy logic in medical equipment.
Implications for clinical practice
For interventional radiologists and interventional cardiologists, the message is direct: AI features that once required buying a brand-new suite may now run on current equipment. That can mean cleaner CBCT reconstructions to guide embolizations and ablations, augmented-reality guidance in complex procedures, and coronary physiology assessment without swapping the whole ecosystem. For administrators, it opens a more predictable modernization path aligned with the journey of radiology’s digital transformation and integration with PACS and structured reporting.
Brazilian context and outlook
In Brazil, where many hemodynamics and interventional radiology services operate with older-generation equipment and tight budgets, the upgrade logic is especially appealing. Upgrading rather than replacing can accelerate access to advanced features in public and private hospitals without the financial shock of a full new installation. Availability will depend on local regulatory clearances and each installed base’s configuration, but the industry trend is clear: incremental, sustainable modernization of the interventional fleet is set to expand in the coming years. As reimbursement pressure and supply-chain costs push providers to squeeze more value from existing capital assets, software-defined upgrades that unlock AI and dose management on hardware already on the floor look less like a stopgap and more like the default modernization playbook for cardiovascular and interventional imaging.
Source: AuntMinnie
